Ursa Medicines
Company
Ursa Medicines develops one asset, in phase 1 (VELA-101 in hyperlipidemia). Mostly small molecule acting on lipid and ceramide metabolism.
- 1
- Asset
- Furthest stage
- Phase 1
- 1
- Trial
- 2
- Signals
Pipeline
1Phase 1, Small molecule, Lipid and ceramide metabolism, hyperlipidemia
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials1
- Signals2
- Similar companies6